In memoriam: Ralph G. Yount
Ralph G. Yount, professor emeritus of chemistry and biochemistry at Washington State University, or WSU, died in June at the age of 92. He was a member of the American Society for Biochemistry and Molecular Biology for 58 years.

Born in 1933, Yount received his Ph.D. in biochemistry from Iowa State University and did his postdoctoral work at Brookhaven, where he was trained as one of the first chemical biologists. He was a member of the faculty of Washington State University for 44 years. His work focused on the way muscles contract, specifically the relationship between muscle protein myosin and adenosine triphosphate, or ATP. His pioneering work on the creation of an ATP analog was critical to research that eventually led to two Nobel prizes and has been cited in more than 4,000 papers.
“Ralph was an icon at WSU, building its biochemistry department and serving as chair of chemistry multiple times,” James Wells, a former doctoral student of Yount’s and now a professor of pharmaceutical science at the University of California, San Francisco, said. “Ralph did so much for me and was my inspiration for science.”
Yount’s accomplishments as a scientist and educator were recognized throughout his career. He received a National Institutes of Health MERIT award in 1986. In 2001, he was the first recipient of WSU’s Eminent Faculty Award, the university’s highest honor for excellence over an extended time. In 2003, he was among the first three faculty members named to the newly established rank of Regents Professor. He was also the first Edward R. Meyer Distinguished Professor of Biochemistry and Chemistry. In 2020, the university presented Yount with an honorary doctorate, and the Ralph G. Yount Distinguished Professorship in Sciences was established in his name.
Yount was a past president of both the Biophysical Society and the Federation of American Societies for Experimental Biology. He was also a long-time editor of the Journal of Biological Chemistry.
He is survived by two daughters.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.